IL165322A0 - Pharmaceutical preparations for oral administration containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents - Google Patents

Pharmaceutical preparations for oral administration containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents

Info

Publication number
IL165322A0
IL165322A0 IL16532203A IL16532203A IL165322A0 IL 165322 A0 IL165322 A0 IL 165322A0 IL 16532203 A IL16532203 A IL 16532203A IL 16532203 A IL16532203 A IL 16532203A IL 165322 A0 IL165322 A0 IL 165322A0
Authority
IL
Israel
Prior art keywords
active ingredients
oral administration
pharmaceutical preparations
exchange resins
agents
Prior art date
Application number
IL16532203A
Other languages
English (en)
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of IL165322A0 publication Critical patent/IL165322A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
IL16532203A 2002-05-31 2003-05-19 Pharmaceutical preparations for oral administration containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents IL165322A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Publications (1)

Publication Number Publication Date
IL165322A0 true IL165322A0 (en) 2006-01-15

Family

ID=29432468

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16532203A IL165322A0 (en) 2002-05-31 2003-05-19 Pharmaceutical preparations for oral administration containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
IL165322A IL165322A (en) 2002-05-31 2004-11-22 Liquid Pharmacy Preparation containing Pradofluxacin Related to Ion Exchanger, Ion Exchanger Intermediated with a Topic Containing Water and Xanthan as Plastic Gel-Formers

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL165322A IL165322A (en) 2002-05-31 2004-11-22 Liquid Pharmacy Preparation containing Pradofluxacin Related to Ion Exchanger, Ion Exchanger Intermediated with a Topic Containing Water and Xanthan as Plastic Gel-Formers

Country Status (28)

Country Link
US (1) US8545829B2 (xx)
EP (1) EP1513500B1 (xx)
JP (2) JP5350574B2 (xx)
KR (3) KR101258373B1 (xx)
CN (1) CN1671361B (xx)
AR (2) AR039861A1 (xx)
AT (1) ATE421317T1 (xx)
AU (1) AU2003242545B2 (xx)
BR (2) BRPI0311511B1 (xx)
CA (1) CA2487648C (xx)
CR (1) CR7598A (xx)
DE (2) DE10224086A1 (xx)
DK (1) DK1513500T3 (xx)
ES (1) ES2319115T3 (xx)
HK (1) HK1083200A1 (xx)
HR (1) HRP20041219B1 (xx)
IL (2) IL165322A0 (xx)
MX (1) MXPA04011820A (xx)
MY (1) MY140953A (xx)
NO (1) NO333939B1 (xx)
PL (1) PL207269B1 (xx)
PT (1) PT1513500E (xx)
RU (1) RU2380091C2 (xx)
SI (1) SI1513500T1 (xx)
TW (1) TWI333422B (xx)
UA (1) UA84270C2 (xx)
WO (1) WO2003101422A2 (xx)
ZA (1) ZA200409616B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
CA2661576A1 (en) * 2006-09-26 2008-04-03 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
CN102046202A (zh) * 2008-03-26 2011-05-04 塔罗制药北美有限公司 用于口服药剂的稳定脂质组合物
EP2544532B1 (en) 2010-03-12 2017-05-03 Monsanto Technology LLC Agrochemical gel compositions
US9918970B2 (en) * 2010-05-19 2018-03-20 Astellas Pharma Inc. Pharmaceutical composition comprising solifenacin
CA2852447A1 (en) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
US11332444B2 (en) 2018-04-25 2022-05-17 Bayer Animal Health Gmbh Method for the hydrolysis of quinolonecarboxylic esters
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204713A (ja) * 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
CA2117266C (en) 1991-10-28 1998-01-06 John Robert Bunger Beverage thickener/emulsifier system
JP3207494B2 (ja) 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DK0882049T3 (da) * 1996-02-23 2003-03-03 Bayer Ag Eventuelt substituerede 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer og deres derivater
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DK1200129T3 (da) * 1999-07-14 2009-01-12 Schering Plough Ltd Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
US20060177414A1 (en) 2006-08-10
KR20120006092A (ko) 2012-01-17
BRPI0311511A8 (pt) 2017-07-11
HRP20041219B1 (hr) 2013-05-31
MXPA04011820A (es) 2005-03-31
JP2006503806A (ja) 2006-02-02
JP5350574B2 (ja) 2013-11-27
EP1513500B1 (de) 2009-01-21
BRPI0311511A (xx) 2005-02-22
CR7598A (es) 2008-07-31
TW200406230A (en) 2004-05-01
IL165322A (en) 2015-11-30
HRP20041219A2 (en) 2006-02-28
WO2003101422A3 (de) 2004-12-09
BRPI0311511B1 (pt) 2018-07-10
TWI333422B (en) 2010-11-21
SI1513500T1 (sl) 2009-06-30
PL207269B1 (pl) 2010-11-30
ZA200409616B (en) 2006-05-31
DK1513500T3 (da) 2009-05-11
RU2004139022A (ru) 2005-07-10
CA2487648A1 (en) 2003-12-11
KR101258373B1 (ko) 2013-04-30
NO333939B1 (no) 2013-10-28
HK1083200A1 (en) 2006-06-30
RU2380091C2 (ru) 2010-01-27
ATE421317T1 (de) 2009-02-15
KR20050010015A (ko) 2005-01-26
PL373456A1 (en) 2005-08-22
PT1513500E (pt) 2009-04-02
JP2011012087A (ja) 2011-01-20
DE50311123D1 (de) 2009-03-12
NO20045700L (no) 2004-12-29
BR0311511A (pt) 2005-02-22
MY140953A (en) 2010-02-12
ES2319115T3 (es) 2009-05-04
CA2487648C (en) 2012-03-13
CN1671361B (zh) 2010-05-12
UA84270C2 (ru) 2008-10-10
US8545829B2 (en) 2013-10-01
EP1513500A2 (de) 2005-03-16
AR039861A1 (es) 2005-03-02
AU2003242545B2 (en) 2010-02-18
AR105798A2 (es) 2017-11-08
DE10224086A1 (de) 2003-12-11
AU2003242545A1 (en) 2003-12-19
WO2003101422A2 (de) 2003-12-11
KR20120123607A (ko) 2012-11-08
CN1671361A (zh) 2005-09-21

Similar Documents

Publication Publication Date Title
HK1083200A1 (en) Pharmaceutical preparations for oral administration, containing ion- exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
HUP0204557A3 (en) Benzazole derivatives, their use as jnk modulators, their preparation and pharmaceutical compositions containing them
GC0000112A (en) Pyrazolopyridines, their preparation, pharmaceutical compositions containing them and their use in medicine (pyrazolopyridine derivatives).
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
HUP0200248A3 (en) Oxamic acids and derivatives as thyroid receptor ligands, pharmaceutical compositions containing them as active ingredient and their use
AU2003286639A8 (en) Mixing and delivery medical syringe system for therapeutic compositions
HUP0203895A3 (en) Substituted azaindoles and pharmaceutical compositions containing them and their use
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
HUP0200859A3 (en) Cyclo-alkyl substituted benzimidazoles, pharmaceutical compositions containing them, their preparation and their use
PL345354A1 (en) 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
HUP0202781A3 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
EG23994A (en) Pharmaceutical compositions for oral and topical administration
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
HUP0200729A3 (en) Hydroxamic acid derivatives, their use and preparation and pharmaceutical compositions containing them
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
HUP0200605A3 (en) Hydroxamic acid derivatives, their preparation and use and pharmaceutical compositions containing them
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie
AU4535800A (en) Novel 6-phenylpurine 9-beta-d-ribonucleosides with antineoplastic activity, their use for preparing pharmaceutical compositions and pharmaceutical preparations containing such compounds
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
GB0201607D0 (en) Formulation for the administration of medicinal substances
AU5249500A (en) Medicinal composition for oral administration
IL103676A0 (en) Pharmaceutical compositions containing hemoglobins as drug delivery agents and methods for the preparation thereof